Discovery Texas Interventional Psychiatry reports strong TMS depression outcomes

Discovery Texas Interventional Psychiatry says its transcranial magnetic stimulation program produced a 73% average drop in depression scores among clients with complete records, based on intake and discharge PHQ-9 data from 22 patients. The results underscore growing interest in non-drug treatment options for major depressive disorder and treatment-resistant depression.

Why it matters: - Discovery Texas Interventional Psychiatry's latest outcomes suggest TMS therapy may help some patients with major depression improve without medication or sedation. - The reported results matter because treatment-resistant depression often leaves patients with few effective options. - The data also add to real-world evidence on a non-drug treatment that patients can receive while remaining awake and resuming normal activities after each session.

What happened: - Discovery Texas Interventional Psychiatry released outcomes data from its TMS therapy program for the reporting period. - Among 22 clients with complete PHQ-9 records at intake and discharge, the average depression score fell from 17.4 to 4.7. - That equals a 73% reduction in average PHQ-9 score. - 86% of clients met the clinical response threshold, defined as at least a 50% reduction from baseline. - 45% of clients reached remission, defined as a discharge PHQ-9 score below 5. - 95% of clients finished treatment in the Minimal or Mild severity range. - 21 of the 22 clients moved into the two lowest PHQ-9 severity bands by discharge. - No client with a complete record ended treatment with a higher score than at intake.

The details: - The reporting group began treatment largely in the Moderate-to-Severe range. - Six clients started at the Severe level. - Twelve clients started at the Moderately Severe level. - PHQ-9 is a 9-item depression screening tool scored from 0 to 27. - DTIP uses PHQ-9 scores to track depression severity. - Client identities were removed for the release, and source records remain in the clinical chart. - TMS is an FDA-cleared, non-drug treatment for major depressive disorder and treatment-resistant depression. - The therapy uses magnetic pulses to stimulate brain areas associated with mood regulation. - DTIP says TMS requires no medication or sedation. - Patients typically remain awake during sessions and return to normal daily activities afterward. - DTIP coordinates with each patient's existing providers throughout treatment. - The practice is located at 4306 Capitol Ave, Dallas, TX 75204, and serves the Dallas-Fort Worth area.

Between the lines: - The results are limited to clients with a documented PHQ-9 score at both intake and discharge, so the dataset is not the same as a full-program census. - Michael Banis, chief growth officer at Discovery MSO, said the figures reflect people who were able to make measurable progress after struggling with medication. - Discovery Texas Interventional Psychiatry is part of Discovery MSO, alongside Discovery Point Retreat. - Discovery Point Retreat treats co-occurring mental health conditions within addiction care, creating a pathway for shared coordination when depression and substance use overlap. - That coordination points to a broader care model that links psychiatric treatment with addiction recovery services.

What's next: - People interested in TMS can request a benefits verification at Discovery Texas Interventional Psychiatry or call (855) 635-4776. - Discovery Point Retreat clients can access TMS through DTIP as part of coordinated care. - DTIP says it will continue coordinating care with patients' existing providers during treatment.

The bottom line: - The report shows strong symptom improvement among a small group of TMS patients with complete records, with most ending treatment in the lowest PHQ-9 severity ranges.